Solutions>CGP>TARGT Indiegene DNA & RNA CGP Kit

TARGT IndiegeneTM DNA & RNA CGP Kit (RUO)
Promise of Precision

TARGT Indiegene (DNA & RNA) CGP Kit (RUO) is one of the largest population specific panel develop by profiling whole-exome and transcriptome of more than 1500 tumour samples from 28 different cancer types.

It includes 1212 unique genes which are known/ novel oncogenic driver mutations as well as tumor suppressor genes with high clinical and research value. These genes are associated with therapeutic, prognostic, and diagnostic implicates in pan cancer.

TARGT Indiegene DNA and RNA CGP Kit (RUO) includes the most comprehensive pan cancer panel constituting a unique set of 1212 genes.

TARGT Indiegene DNA-based kit (4.4 Mb panel) profiles 1212 genes for detection of Genomic Alterations (SNVs; Indels; CNA; Gene Fusions) along with Immunotherapy Biomarkers (TMB [only for solid biopsy] MSI).

TARGT Indiegene RNA-based kit (0.8 Mb panel) profiles 299 genes for detection of common, rare as well as novel fusion partners.

Book Your Kit
Compare Our Kits

TargtIndiengeCGPKit

 
  Available in 2 Variants
DNA 48 RXNS 96 RXNS
RNA 48 RXNS 96 RXNS
Features & Benefits

Consolidated assay

  • Population derive cancer specific assay to asses current and emerging biomarkers known/ novel oncogenic driver mutations with high clinical and research value

Flexibility Integration

  • Compatible with Low input requirements wide sample sources for pan solid tumors and multiple sequencing platforms

Complete Coverage and Depth

  • Covering complete exonic regions of 1212 genes (4.4 Mb) with >99% coverage

Superior Performance

  • Strong capture performance against GC-rich regions as well as higher quality in coverage and uniformity

Proven & Reliable Results

  • Generate accurate results using an assay having high performance matrix : 100% specificity and >98% sensitivity. 100% accuracy, precision, and reproducibility. Our Lod is 5% for SNV and 10% for InDels (<10 bp)

Cost and Time Effective

  • Less sequencing data instead of whole exome sequencing makes it cost and time effective

Comprehensive and Simplified Reports

  • Comprehensive analysis and reporting in case of DNA based kit of small variants, insertions, deletions, amplifications, gene fusion/skipping in multiple genes simultaneously with Immunotherapy Biomarkers (TMB [only for solid biopsy] MSI)

Resources

TARGT Indiegene DNA & RNA CGP Kit Library Preparation
Explore 4baseCare Solutions
Book Your Kit
Compare Our Kits
loader